HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuyasu Terashima Selected Research

Thrombosis (Thrombus)

1/2022Impact of Optimal Preparation Before Drug-Coated Balloon Dilatation for De Novo Lesion in Patients With Coronary Artery Disease.
10/2018In vivo tissue characterization of human atherosclerotic plaques by optical coherence tomography: A directional coronary atherectomy study with histopathologic confirmation.
10/2015Impact of lesion morphology on angiographic and clinical outcomes in patients with chronic total occlusion after recanalization with drug-eluting stents: a multislice computed tomography study.
5/2014Impact of sirolimus-eluting stent fractures without early cardiac events on long-term clinical outcomes: a multislice computed tomography study.
4/2012Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study.
1/2011Very late sirolimus-eluting stent thrombosis due to stent fracture and late-acquired incomplete stent apposition detected on multislice computed tomography.
12/2009Late-acquired stent malapposition after sirolimus-eluting stent implantation following acute coronary syndrome: angiographic, IVUS, OCT and coronary angioscopic observation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuyasu Terashima Research Topics

Disease

24Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 11/2002
17Atherosclerotic Plaque (Atheroma)
09/2016 - 08/2007
9Hyperplasia
01/2019 - 11/2005
9Angina Pectoris
01/2015 - 11/2002
7Thrombosis (Thrombus)
01/2022 - 12/2009
6Pathologic Constriction (Stenosis)
12/2023 - 11/2005
6Atherosclerosis
03/2015 - 11/2002
6Diabetes Mellitus
05/2014 - 02/2006
5Neointima
01/2019 - 02/2006
5Myocardial Infarction
10/2015 - 09/2006
5Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 03/2009
4Rupture
04/2012 - 03/2009
3Hypertension (High Blood Pressure)
09/2015 - 02/2007
3Unstable Angina
04/2013 - 10/2005
2Death (Near-Death Experience)
10/2015 - 05/2014
2Stable Angina
07/2013 - 07/2009
2Acute Coronary Syndrome
04/2013 - 12/2009
2AIDS-Related Complex (ARC)
05/2012 - 11/2005
2Coronary Stenosis (Coronary Artery Stenosis)
03/2012 - 02/2012
2Coronary Vasospasm (Coronary Artery Vasospasm)
03/2012 - 02/2012
1Arteritis
12/2023
1Acute Kidney Injury (Acute Renal Failure)
11/2016
1Chronic Renal Insufficiency
11/2016
1Hypercholesterolemia
09/2016
1Intussusception
06/2012
1Dyslipidemias (Dyslipidemia)
04/2012
1Spasm (Spasms)
03/2012
1Muscle Spasticity (Spastic)
03/2012
1Prolapse
03/2012
1Fibrosis (Cirrhosis)
02/2012
1Necrosis
02/2012
1Hypersensitivity (Allergy)
12/2009
1Flushing
03/2008
1Hyperlipidemias (Hyperlipidemia)
02/2007
1Inflammation (Inflammations)
09/2006

Drug/Important Bio-Agent (IBA)

19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2016 - 07/2009
12Sirolimus (Rapamycin)FDA Link
05/2014 - 11/2005
9LipidsIBA
10/2018 - 07/2009
8MetalsIBA
01/2019 - 11/2005
4CalciumIBA
09/2013 - 11/2005
4NADPH Oxidases (NAD(P)H oxidase)IBA
06/2009 - 11/2002
3omega-Chloroacetophenone (Mace)IBA
10/2015 - 03/2009
3LDL CholesterolIBA
09/2015 - 07/2009
3Pravastatin (Pravachol)FDA LinkGeneric
01/2015 - 06/2013
2CholesterolIBA
09/2016 - 07/2013
2Amlodipine (Norvasc)FDA LinkGeneric
09/2015 - 02/2012
2LDL Lipoproteins (beta Lipoproteins)IBA
09/2015 - 07/2009
2pitavastatin (itavastatin)FDA Link
01/2015 - 06/2013
2FluvastatinFDA Link
02/2014 - 07/2009
2Docosahexaenoic AcidsIBA
01/2014 - 01/2013
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2013 - 01/2013
2oxidized low density lipoproteinIBA
01/2013 - 11/2002
2Phenobarbital (Luminal)FDA Link
03/2012 - 02/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2009 - 01/2007
1tocilizumab (atlizumab)FDA Link
12/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2023
1Contrast MediaIBA
01/2016
1Atenolol (Tenormin)FDA LinkGeneric
09/2015
1pigment epithelium-derived factorIBA
03/2015
1Uric Acid (Urate)IBA
06/2014
1Lipoprotein(a)IBA
04/2014
1Ezetimibe (Zetia)FDA Link
02/2014
1Platelet Activating FactorIBA
04/2013
1Arachidonic Acid (Vitamin F)IBA
01/2013
1C-Reactive ProteinIBA
01/2013
1Eicosapentaenoic AcidIBA
01/2013
1Atorvastatin (Lipitor)FDA Link
04/2012
1Ergonovine (Ergometrine)IBA
03/2012
1Telmisartan (Micardis)FDA Link
02/2012
1Ringer's LactateIBA
03/2008
1Interleukin-6 (Interleukin 6)IBA
09/2006
1CD40 Ligand (CD40L)IBA
09/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2005
1Oxidoreductases (Dehydrogenase)IBA
11/2002
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
11/2002
1Superoxides (Superoxide)IBA
11/2002
1NAD (NADH)IBA
11/2002

Therapy/Procedure

25Stents
12/2023 - 11/2005
20Therapeutics
09/2016 - 07/2009
10Percutaneous Coronary Intervention
11/2016 - 02/2006
4Drug-Eluting Stents
01/2022 - 05/2010
1Renal Dialysis (Hemodialysis)
11/2016
1Catheters
06/2012
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2009